CAS No. 939791-38-5
Batch:
Purity:99.32
Chemical Structure
Check the
PF-562271 Besylate
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| IUPAC Name | benzenesulfonic acid;N-methyl-N-[3-[[[2-[(2-oxo-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]methyl]-2-pyridinyl]methanesulfonamide | |
|---|---|---|
| CAS Number | 939791-38-5 | |
| Molecular Formula |
C21H20F3N7O3S.C6H6O3S |
|
| Molecular Weight (MW) | 665.66 | |
| SMILES | CN(C1=C(C=CC=N1)CNC2=NC(=NC=C2C(F)(F)F)NC3=CC4=C(C=C3)NC(=O)C4)S(=O)(=O)C.C1=CC=C(C=C1)S(=O)(=O)O | |
| InChIKey | LKLWTLXTOVZFAE-UHFFFAOYSA-N |
PF-562271 Besylate is a potent, ATP-competitive inhibitor of FAK (IC50 1.5 nM) with approximately 10-fold lower potency for Pyk2. By blocking FAK auto-phosphorylation, it disrupts downstream signaling cascades including the PI3K/AKT and ERK pathways. This target inhibition impairs tumor cell migration, invasion, proliferation, and survival, while demonstrating antiangiogenic and broad antitumor activity in preclinical cancer models.
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| 4-Methylpyridine | 25 mg/mL |
| DMSO |
0.4 mg/mL
(0.6 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.) |
| Water | Insoluble |
| DMSO |
100 mg/mL
(150.22 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
- PF-562271 Besylate Clinical Trials
- PF-562271 Besylate Solubility in DMSO
- PF-562271 Besylate Stock Solution
- PF-562271 Besylate Storage
- PF-562271 Besylate Stability
- PF-562271 Besylate Molecular Weight
- PF-562271 Besylate SMILES
- PF-562271 Besylate Chemical Structure (2D and 3D)
- PF-562271 Besylate SDS|MSDS
Note: Technical data last updated: Sep 1, 2026.